APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tropicamide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tropicamide Industry Growth and Trends Forecast to 2032

19 December 2025121 pages

Choose your research edition.

Industry ResearchTropicamide Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Tropicamide Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Tropicamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tropicamide Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Tropicamide Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Tropicamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tropicamide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tropicamide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tropicamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tropicamide include Novartis, Watson Laboratories, Wakamoto, Visufarma, Vega Pharma, Unimed Pharma, Thea Pharma, Roemmers and Polfa Warszawa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tropicamide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tropicamide market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tropicamide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tropicamide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tropicamide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tropicamide Market by Company

Novartis

Watson Laboratories

Wakamoto

Visufarma

Vega Pharma

Unimed Pharma

Thea Pharma

Roemmers

Polfa Warszawa

Pharma Stulln

Nippon Tenganyaku Kenkyujo

Miza Pharmaceuticals

Laboratorios Sophia

Edol

Dioptic Pharmaceuticals

Chauvin Ankerpharm

Bausch Health

Alcon Laboratories

Akorn

Agepha Pharma

Tropicamide Segment by Type

5mg

10mg

Tropicamide Segment by Application

Hospital

Drug Store

Tropicamide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tropicamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tropicamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tropicamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tropicamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tropicamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5mg Table 2. Major Company of 10mg Table 3. Global Tropicamide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tropicamide Sales by Type (2021-2026) & (K Units) Table 5. Global Tropicamide Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tropicamide Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tropicamide Sales Market Share in Value by Type (2021-2026) Table 8. Global Tropicamide Price by Type (2021-2026) & (US$/Unit) Table 9. Global Tropicamide Sales by Type (2027-2032) & (K Units) Table 10. Global Tropicamide Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tropicamide Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tropicamide Sales Market Share in Value by Type (2027-2032) Table 13. Global Tropicamide Price by Type (2027-2032) & (US$/Unit) Table 14. North America Tropicamide Sales by Type (2021-2026) & (K Units) Table 15. North America Tropicamide Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tropicamide Sales by Type (2021-2026) & (K Units) Table 17. Europe Tropicamide Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tropicamide Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Tropicamide Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tropicamide Sales by Type (2021-2026) & (K Units) Table 21. Latin America Tropicamide Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tropicamide Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Tropicamide Sales by Type (2021-2026) & (US$ Million) Table 24. Tropicamide Industry Trends Table 25. Tropicamide Industry Drivers Table 26. Tropicamide Industry Opportunities and Challenges Table 27. Tropicamide Industry Restraints Table 28. Global Tropicamide Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tropicamide Revenue Market Share by Company (2021-2026) Table 30. Global Tropicamide Sales by Company (2021-2026) & (K Units) Table 31. Global Tropicamide Sales Share by Company (2021-2026) Table 32. Global Tropicamide Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Tropicamide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tropicamide Major Company Production Sites and Headquarters Table 35. Global Tropicamide Company, Product Type & Application Table 36. Global Tropicamide Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tropicamide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tropicamide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tropicamide Sales by Region (2021-2026) & (K Units) Table 41. Global Tropicamide Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tropicamide Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tropicamide Sales Market Share in Value by Region (2021-2026) Table 44. Global Tropicamide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Tropicamide Sales by Region (2027-2032) & (K Units) Table 46. Global Tropicamide Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tropicamide Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tropicamide Sales Market Share in Value by Region (2027-2032) Table 49. Global Tropicamide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Tropicamide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tropicamide Sales by Application (2021-2026) & (K Units) Table 52. Global Tropicamide Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tropicamide Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tropicamide Sales Market Share in Value by Application (2021-2026) Table 55. Global Tropicamide Price by Application (2021-2026) & (US$/Unit) Table 56. Global Tropicamide Sales by Application (2027-2032) & (K Units) Table 57. Global Tropicamide Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tropicamide Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tropicamide Sales Market Share in Value by Application (2027-2032) Table 60. Global Tropicamide Price by Application (2027-2032) & (US$/Unit) Table 61. North America Tropicamide Sales by Application (2021-2026) & (K Units) Table 62. North America Tropicamide Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tropicamide Sales by Application (2021-2026) & (K Units) Table 64. Europe Tropicamide Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tropicamide Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Tropicamide Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tropicamide Sales by Application (2021-2026) & (K Units) Table 68. Latin America Tropicamide Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tropicamide Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Tropicamide Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Novartis Tropicamide Product Portfolio Table 75. Novartis Recent Development Table 76. Watson Laboratories Company Information Table 77. Watson Laboratories Business Overview Table 78. Watson Laboratories Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Watson Laboratories Tropicamide Product Portfolio Table 80. Watson Laboratories Recent Development Table 81. Wakamoto Company Information Table 82. Wakamoto Business Overview Table 83. Wakamoto Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Wakamoto Tropicamide Product Portfolio Table 85. Wakamoto Recent Development Table 86. Visufarma Company Information Table 87. Visufarma Business Overview Table 88. Visufarma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Visufarma Tropicamide Product Portfolio Table 90. Visufarma Recent Development Table 91. Vega Pharma Company Information Table 92. Vega Pharma Business Overview Table 93. Vega Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Vega Pharma Tropicamide Product Portfolio Table 95. Vega Pharma Recent Development Table 96. Unimed Pharma Company Information Table 97. Unimed Pharma Business Overview Table 98. Unimed Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Unimed Pharma Tropicamide Product Portfolio Table 100. Unimed Pharma Recent Development Table 101. Thea Pharma Company Information Table 102. Thea Pharma Business Overview Table 103. Thea Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Thea Pharma Tropicamide Product Portfolio Table 105. Thea Pharma Recent Development Table 106. Roemmers Company Information Table 107. Roemmers Business Overview Table 108. Roemmers Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Roemmers Tropicamide Product Portfolio Table 110. Roemmers Recent Development Table 111. Polfa Warszawa Company Information Table 112. Polfa Warszawa Business Overview Table 113. Polfa Warszawa Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Polfa Warszawa Tropicamide Product Portfolio Table 115. Polfa Warszawa Recent Development Table 116. Pharma Stulln Company Information Table 117. Pharma Stulln Business Overview Table 118. Pharma Stulln Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Pharma Stulln Tropicamide Product Portfolio Table 120. Pharma Stulln Recent Development Table 121. Nippon Tenganyaku Kenkyujo Company Information Table 122. Nippon Tenganyaku Kenkyujo Business Overview Table 123. Nippon Tenganyaku Kenkyujo Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Nippon Tenganyaku Kenkyujo Tropicamide Product Portfolio Table 125. Nippon Tenganyaku Kenkyujo Recent Development Table 126. Miza Pharmaceuticals Company Information Table 127. Miza Pharmaceuticals Business Overview Table 128. Miza Pharmaceuticals Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Miza Pharmaceuticals Tropicamide Product Portfolio Table 130. Miza Pharmaceuticals Recent Development Table 131. Laboratorios Sophia Company Information Table 132. Laboratorios Sophia Business Overview Table 133. Laboratorios Sophia Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Laboratorios Sophia Tropicamide Product Portfolio Table 135. Laboratorios Sophia Recent Development Table 136. Edol Company Information Table 137. Edol Business Overview Table 138. Edol Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Edol Tropicamide Product Portfolio Table 140. Edol Recent Development Table 141. Dioptic Pharmaceuticals Company Information Table 142. Dioptic Pharmaceuticals Business Overview Table 143. Dioptic Pharmaceuticals Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Dioptic Pharmaceuticals Tropicamide Product Portfolio Table 145. Dioptic Pharmaceuticals Recent Development Table 146. Chauvin Ankerpharm Company Information Table 147. Chauvin Ankerpharm Business Overview Table 148. Chauvin Ankerpharm Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Chauvin Ankerpharm Tropicamide Product Portfolio Table 150. Chauvin Ankerpharm Recent Development Table 151. Bausch Health Company Information Table 152. Bausch Health Business Overview Table 153. Bausch Health Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Bausch Health Tropicamide Product Portfolio Table 155. Bausch Health Recent Development Table 156. Alcon Laboratories Company Information Table 157. Alcon Laboratories Business Overview Table 158. Alcon Laboratories Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Alcon Laboratories Tropicamide Product Portfolio Table 160. Alcon Laboratories Recent Development Table 161. Akorn Company Information Table 162. Akorn Business Overview Table 163. Akorn Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Akorn Tropicamide Product Portfolio Table 165. Akorn Recent Development Table 166. Agepha Pharma Company Information Table 167. Agepha Pharma Business Overview Table 168. Agepha Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Agepha Pharma Tropicamide Product Portfolio Table 170. Agepha Pharma Recent Development Table 171. North America Tropicamide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. North America Tropicamide Sales by Country (2021-2026) & (K Units) Table 173. North America Tropicamide Sales Market Share by Country (2021-2026) Table 174. North America Tropicamide Sales Forecast by Country (2027-2032) & (K Units) Table 175. North America Tropicamide Sales Market Share Forecast by Country (2027-2032) Table 176. North America Tropicamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Tropicamide Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Tropicamide Market Share by Country (2021-2026) Table 179. North America Tropicamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Tropicamide Market Share Forecast by Country (2027-2032) Table 181. Europe Tropicamide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Europe Tropicamide Sales by Country (2021-2026) & (K Units) Table 183. Europe Tropicamide Sales Market Share by Country (2021-2026) Table 184. Europe Tropicamide Sales Forecast by Country (2027-2032) & (K Units) Table 185. Europe Tropicamide Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Tropicamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Tropicamide Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Tropicamide Market Share by Country (2021-2026) Table 189. Europe Tropicamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Tropicamide Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Tropicamide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Tropicamide Sales by Country (2021-2026) & (K Units) Table 193. Asia-Pacific Tropicamide Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Tropicamide Sales Forecast by Country (2027-2032) & (K Units) Table 195. Asia-Pacific Tropicamide Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Tropicamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Tropicamide Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Tropicamide Market Share by Country (2021-2026) Table 199. Asia-Pacific Tropicamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Tropicamide Market Share Forecast by Country (2027-2032) Table 201. Latin America Tropicamide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Latin America Tropicamide Sales by Country (2021-2026) & (K Units) Table 203. Latin America Tropicamide Sales Market Share by Country (2021-2026) Table 204. Latin America Tropicamide Sales Forecast by Country (2027-2032) & (K Units) Table 205. Latin America Tropicamide Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Tropicamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Tropicamide Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Tropicamide Market Share by Country (2021-2026) Table 209. Latin America Tropicamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Tropicamide Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Tropicamide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Tropicamide Sales by Country (2021-2026) & (K Units) Table 213. Middle East and Africa Tropicamide Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Tropicamide Sales Forecast by Country (2027-2032) & (K Units) Table 215. Middle East and Africa Tropicamide Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Tropicamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Tropicamide Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Tropicamide Market Share by Country (2021-2026) Table 219. Middle East and Africa Tropicamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Tropicamide Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Tropicamide Distributors List Table 224. Tropicamide Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Tropicamide Image Figure 2. Global Tropicamide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tropicamide Market Size (2021-2032) & (US$ Million) Figure 4. Global Tropicamide Sales (2021-2032) & (K Units) Figure 5. 5mg Image Figure 6. Global 5mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 10mg Image Figure 8. Global 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Tropicamide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tropicamide Market Share by Type 2025 VS 2032 Figure 11. North America Tropicamide Sales Market Share in Volume by Type in 2025 Figure 12. North America Tropicamide Sales Market Share in Value by Type in 2025 Figure 13. Europe Tropicamide Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tropicamide Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tropicamide Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tropicamide Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tropicamide Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tropicamide Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tropicamide Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tropicamide Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tropicamide Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Drug Store Image Figure 26. Global Drug Store Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Tropicamide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Tropicamide Market Share by Application 2025 VS 2032 Figure 29. North America Tropicamide Sales Market Share in Volume by Application in 2025 Figure 30. North America Tropicamide Sales Market Share in Value by Application in 2025 Figure 31. Europe Tropicamide Sales Market Share in Volume by Application in 2025 Figure 32. Europe Tropicamide Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Tropicamide Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Tropicamide Sales Market Share in Value by Application in 2025 Figure 35. Latin America Tropicamide Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Tropicamide Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Tropicamide Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Tropicamide Sales Market Share in Value by Application in 2025 Figure 39. North America Tropicamide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Tropicamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Tropicamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Tropicamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Tropicamide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Tropicamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Tropicamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Tropicamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Tropicamide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Tropicamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Tropicamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Tropicamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Tropicamide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Tropicamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Tropicamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Tropicamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Tropicamide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Tropicamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Tropicamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Tropicamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Tropicamide Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Tropicamide Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 10mg
Applications
  • Hospital
  • Drug Store
Companies covered
  • Novartis
  • Watson Laboratories
  • Wakamoto
  • Visufarma
  • Vega Pharma
  • Unimed Pharma
  • Thea Pharma
  • Roemmers
  • Polfa Warszawa
  • Pharma Stulln
  • Nippon Tenganyaku Kenkyujo
  • Miza Pharmaceuticals
  • Laboratorios Sophia
  • Edol
  • Dioptic Pharmaceuticals
  • Chauvin Ankerpharm
  • Bausch Health
  • Alcon Laboratories
  • Akorn
  • Agepha Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tropicamide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tropicamide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tropicamide Market by Type
  6. 1.3.1 5mg
  7. 1.3.2 10mg
  8. 1.4 Global Tropicamide Market Size by Type
  9. 1.4.1 Global Tropicamide Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tropicamide Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tropicamide Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tropicamide Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tropicamide Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tropicamide Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tropicamide Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tropicamide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tropicamide Industry Trends
  2. 2.2 Tropicamide Industry Drivers
  3. 2.3 Tropicamide Industry Opportunities and Challenges
  4. 2.4 Tropicamide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tropicamide Revenue (2021-2026)
  2. 3.2 Global Top Players by Tropicamide Sales (2021-2026)
  3. 3.3 Global Top Players by Tropicamide Price (2021-2026)
  4. 3.4 Global Tropicamide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tropicamide Major Company Production Sites & Headquarters
  6. 3.6 Global Tropicamide Company, Product Type & Application
  7. 3.7 Global Tropicamide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tropicamide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tropicamide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tropicamide Tier 1, Tier 2, and Tier 3
4 Tropicamide Regional Status and Outlook
  1. 4.1 Global Tropicamide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tropicamide Historic Market Size by Region
  3. 4.2.1 Global Tropicamide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tropicamide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tropicamide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tropicamide Forecasted Market Size by Region
  7. 4.3.1 Global Tropicamide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tropicamide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tropicamide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tropicamide by Application
  1. 5.1 Tropicamide Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Tropicamide Market Size by Application
  5. 5.2.1 Global Tropicamide Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Tropicamide Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Tropicamide Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Tropicamide Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Tropicamide Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Tropicamide Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Tropicamide Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Tropicamide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Tropicamide Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Watson Laboratories
  8. 6.2.1 Watson Laboratories Company Information
  9. 6.2.2 Watson Laboratories Business Overview
  10. 6.2.3 Watson Laboratories Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Watson Laboratories Tropicamide Product Portfolio
  12. 6.2.5 Watson Laboratories Recent Developments
  13. 6.3 Wakamoto
  14. 6.3.1 Wakamoto Company Information
  15. 6.3.2 Wakamoto Business Overview
  16. 6.3.3 Wakamoto Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Wakamoto Tropicamide Product Portfolio
  18. 6.3.5 Wakamoto Recent Developments
  19. 6.4 Visufarma
  20. 6.4.1 Visufarma Company Information
  21. 6.4.2 Visufarma Business Overview
  22. 6.4.3 Visufarma Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Visufarma Tropicamide Product Portfolio
  24. 6.4.5 Visufarma Recent Developments
  25. 6.5 Vega Pharma
  26. 6.5.1 Vega Pharma Company Information
  27. 6.5.2 Vega Pharma Business Overview
  28. 6.5.3 Vega Pharma Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Vega Pharma Tropicamide Product Portfolio
  30. 6.5.5 Vega Pharma Recent Developments
  31. 6.6 Unimed Pharma
  32. 6.6.1 Unimed Pharma Company Information
  33. 6.6.2 Unimed Pharma Business Overview
  34. 6.6.3 Unimed Pharma Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Unimed Pharma Tropicamide Product Portfolio
  36. 6.6.5 Unimed Pharma Recent Developments
  37. 6.7 Thea Pharma
  38. 6.7.1 Thea Pharma Company Information
  39. 6.7.2 Thea Pharma Business Overview
  40. 6.7.3 Thea Pharma Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Thea Pharma Tropicamide Product Portfolio
  42. 6.7.5 Thea Pharma Recent Developments
  43. 6.8 Roemmers
  44. 6.8.1 Roemmers Company Information
  45. 6.8.2 Roemmers Business Overview
  46. 6.8.3 Roemmers Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Roemmers Tropicamide Product Portfolio
  48. 6.8.5 Roemmers Recent Developments
  49. 6.9 Polfa Warszawa
  50. 6.9.1 Polfa Warszawa Company Information
  51. 6.9.2 Polfa Warszawa Business Overview
  52. 6.9.3 Polfa Warszawa Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Polfa Warszawa Tropicamide Product Portfolio
  54. 6.9.5 Polfa Warszawa Recent Developments
  55. 6.10 Pharma Stulln
  56. 6.10.1 Pharma Stulln Company Information
  57. 6.10.2 Pharma Stulln Business Overview
  58. 6.10.3 Pharma Stulln Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Pharma Stulln Tropicamide Product Portfolio
  60. 6.10.5 Pharma Stulln Recent Developments
  61. 6.11 Nippon Tenganyaku Kenkyujo
  62. 6.11.1 Nippon Tenganyaku Kenkyujo Company Information
  63. 6.11.2 Nippon Tenganyaku Kenkyujo Business Overview
  64. 6.11.3 Nippon Tenganyaku Kenkyujo Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Nippon Tenganyaku Kenkyujo Tropicamide Product Portfolio
  66. 6.11.5 Nippon Tenganyaku Kenkyujo Recent Developments
  67. 6.12 Miza Pharmaceuticals
  68. 6.12.1 Miza Pharmaceuticals Company Information
  69. 6.12.2 Miza Pharmaceuticals Business Overview
  70. 6.12.3 Miza Pharmaceuticals Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Miza Pharmaceuticals Tropicamide Product Portfolio
  72. 6.12.5 Miza Pharmaceuticals Recent Developments
  73. 6.13 Laboratorios Sophia
  74. 6.13.1 Laboratorios Sophia Company Information
  75. 6.13.2 Laboratorios Sophia Business Overview
  76. 6.13.3 Laboratorios Sophia Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Laboratorios Sophia Tropicamide Product Portfolio
  78. 6.13.5 Laboratorios Sophia Recent Developments
  79. 6.14 Edol
  80. 6.14.1 Edol Company Information
  81. 6.14.2 Edol Business Overview
  82. 6.14.3 Edol Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Edol Tropicamide Product Portfolio
  84. 6.14.5 Edol Recent Developments
  85. 6.15 Dioptic Pharmaceuticals
  86. 6.15.1 Dioptic Pharmaceuticals Company Information
  87. 6.15.2 Dioptic Pharmaceuticals Business Overview
  88. 6.15.3 Dioptic Pharmaceuticals Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dioptic Pharmaceuticals Tropicamide Product Portfolio
  90. 6.15.5 Dioptic Pharmaceuticals Recent Developments
  91. 6.16 Chauvin Ankerpharm
  92. 6.16.1 Chauvin Ankerpharm Company Information
  93. 6.16.2 Chauvin Ankerpharm Business Overview
  94. 6.16.3 Chauvin Ankerpharm Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Chauvin Ankerpharm Tropicamide Product Portfolio
  96. 6.16.5 Chauvin Ankerpharm Recent Developments
  97. 6.17 Bausch Health
  98. 6.17.1 Bausch Health Company Information
  99. 6.17.2 Bausch Health Business Overview
  100. 6.17.3 Bausch Health Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Bausch Health Tropicamide Product Portfolio
  102. 6.17.5 Bausch Health Recent Developments
  103. 6.18 Alcon Laboratories
  104. 6.18.1 Alcon Laboratories Company Information
  105. 6.18.2 Alcon Laboratories Business Overview
  106. 6.18.3 Alcon Laboratories Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Alcon Laboratories Tropicamide Product Portfolio
  108. 6.18.5 Alcon Laboratories Recent Developments
  109. 6.19 Akorn
  110. 6.19.1 Akorn Company Information
  111. 6.19.2 Akorn Business Overview
  112. 6.19.3 Akorn Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Akorn Tropicamide Product Portfolio
  114. 6.19.5 Akorn Recent Developments
  115. 6.20 Agepha Pharma
  116. 6.20.1 Agepha Pharma Company Information
  117. 6.20.2 Agepha Pharma Business Overview
  118. 6.20.3 Agepha Pharma Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Agepha Pharma Tropicamide Product Portfolio
  120. 6.20.5 Agepha Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Tropicamide Sales by Country
  2. 7.1.1 North America Tropicamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tropicamide Sales by Country (2021-2026)
  4. 7.1.3 North America Tropicamide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tropicamide Market Size by Country
  6. 7.2.1 North America Tropicamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tropicamide Market Size by Country (2021-2026)
  8. 7.2.3 North America Tropicamide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tropicamide Sales by Country
  2. 8.1.1 Europe Tropicamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tropicamide Sales by Country (2021-2026)
  4. 8.1.3 Europe Tropicamide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tropicamide Market Size by Country
  6. 8.2.1 Europe Tropicamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tropicamide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tropicamide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tropicamide Sales by Country
  2. 9.1.1 Asia-Pacific Tropicamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tropicamide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tropicamide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tropicamide Market Size by Country
  6. 9.2.1 Asia-Pacific Tropicamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tropicamide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tropicamide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tropicamide Sales by Country
  2. 10.1.1 South America Tropicamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tropicamide Sales by Country (2021-2026)
  4. 10.1.3 South America Tropicamide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tropicamide Market Size by Country
  6. 10.2.1 South America Tropicamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tropicamide Market Size by Country (2021-2026)
  8. 10.2.3 South America Tropicamide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tropicamide Sales by Country
  2. 11.1.1 Middle East and Africa Tropicamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tropicamide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tropicamide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tropicamide Market Size by Country
  6. 11.2.1 Middle East and Africa Tropicamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tropicamide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tropicamide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tropicamide Value Chain Analysis
  2. 12.1.1 Tropicamide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tropicamide Production Mode & Process
  7. 12.2 Tropicamide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tropicamide Distributors
  10. 12.2.3 Tropicamide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst